Inhibitors of the Tyrosine Kinase Ephb4. Part 1: Structure-Based Design and Optimization of a Series of 2,4-Bis-Anilinopyrimidines.
Bardelle, C., Cross, D., Davenport, S., Kettle, J.G., Ko, E.J., Leach, A.G., Mortlock, A., Read, J., Roberts, N.J., Robins, P., Williams, E.J.(2008) Bioorg Med Chem Lett 18: 2776
- PubMed: 18434142 
- DOI: https://doi.org/10.1016/j.bmcl.2008.04.015
- Primary Citation of Related Structures:  
2VWU, 2VWV, 2VWW, 2VX0 - PubMed Abstract: 
A series of bis-anilinopyrimidines have been identified as potent inhibitors of the tyrosine kinase EphB4. Structural information from two alternative series identified from screening efforts was combined to identify the initial leads.
Organizational Affiliation: 
AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.